Gilead will challenge US government patent on PrEP drug TruvadaGilead Sciences has said it plans to challenge patents held by the US government on the use of Share XGilead will challenge US government patent on PrEP drug Truvadahttps://pharmaphorum.com/news/gilead-will-challenge-us-government-patent-on-prep-drug-truvada/
Novartis secures initial block on Gilenya generics in USNovartis has won a temporary reprieve from generic competition to its big-selling oral multiple sclerosis therapy Gilenya in Share XNovartis secures initial block on Gilenya generics in UShttps://pharmaphorum.com/news/novartis-secures-initial-block-on-gilenya-generics-in-us/
EU Pharmaceutical Law ForumDIG DEEPER INTO CUTTING EDGE TOPICS Share XEU Pharmaceutical Law Forumhttps://pharmaphorum.com/events/eu-pharmaceutical-law-forum/
SMi’s release speaker interview Anita Burrell, speaker at Biosimilars USABiosimilars USA conference information Share XSMi’s release speaker interview Anita Burrell, speaker at Biosimilars USAhttps://pharmaphorum.com/partner-content/smis-release-speaker-interview-anita-burrell-speaker-at-biosimilars-usa/